The week that took us from August to September was one for the books over at BoomTown, especially if you’re 12.

Kara spent Monday morning at Activision Blizzard (ATVI), where they are pushing forward with the entire Guitar Hero line, even as the game industry faces a nearly 50 percent decline in U.S. sales this year. Kara got to play hero to several of the forthcoming releases, including previewing the much anticipated DJ Hero console.

The youth movement continued with the fancy bar graph from Forrester Research’s annual “State of Consumers and Technology,” which drove home an important fact of life for media outlets. All the money being spent on new media expansion is a fight for the young; older consumers are sticking to more reliable fare.

BoomTown wasn’t just about the kids though, as 23andMe co-founder Linda Avey announced her exit from the gene-juicing business to focus on a foundation related to Alzheimer’s research. Avey co-founded 23andMe with Anne Wojcicki in 2006 with early money from Genentech (DNA), Google (GOOG) and New Enterprise Associates, as well as Wojcicki’s husband, Google co-founder Sergey Brin.

While BoomTown was keepin’ it real with the kids, Digital Daily was abuzz with a spate of iPhone news. John started Monday off on the topic of the Sept. 9 iPod event with confirmation that music, indeed, will be center stage. In the Apple world, that means iPods and iTunes, though Beatles fans are keeping their fingers crossed.

Readers got a compare-and-contrast of Apple’s (AAPL) foreign and domestic policy when John covered a potential two-carrier system in China and the long-awaited stateside activation of MMS features in the iPhone OS3. Meaning that while China may get the iPhone carrier flexibility so far absent in the U.S. market, American consumers are just about to get a new feature that’s been standard on every smartphone for a year or more.

MediaMemo covered a fluid week in the world of media giants and Top Chefs. Disney (DIS) went off to the mines and instead of seven dwarfs, found Marvel and the rights to its 5,000-character portfolio. Disney CEO Bob Iger didn’t think $4 billion was too much to pay to bring Iron Man and friends to the happiest media empire on earth and is sure the company will benefit from such “rich intellectual property.”

If the Disney vault got 5,000 new friends this week, eBay said goodbye to one long-time partner. Peter reported that the long, difficult breakup between eBay and Skype was finalized when eBay sold a 65 percent stake in the VOIP juggernaut to the internationally mixed bag of Silver Lake, Index ventures, Andreessen Horowitz and a Canadian pension fund.

Peter rounded out the week of motion with lots of changes in Google’s ranks. The search giant shuffled the chairs with David Fischer moving out of the self-serve ad business with no sign yet of a replacement. Google China saw the big chair turn upside-down when Kai-Fu Lee announced that he’d leave the company this month to begin his own venture. Lee will be replaced by the tag team of Boon-Lock Yeo and John Liu, who will oversee engineering and business, respectively.

Not all Google’s shifts were outbound though. “Charlie’s Café” at the main campus got its Top Chef back after Preeti Mistry failed to make the cut on the Las Vegas iteration of the popular TV show. Regular fans of the show weren’t surprised by her dismissal, but at least Google can put one in the plus column this week.

Over at The Mossberg Solution, Katie took aim at a possible answer to a question plaguing all image-conscious technophiles: Yea or nay to the omnipresent Bluetooth earpiece. Plantronics (PLT) and Aliph, maker of the Jawbone, both say yea and are upping the ante on the recently reviled symbol of cellphone userdom. Katie reviewed the fashion-forward Discovery 975 and Jawbone Prime, each designed to separate its users from $130. In exchange, they’ll get redesigned outsides and some new features that might even put one back in Brad Pitt’s ear.

British lawmakers voted Monday to allow the use of human-animal embryos for research after an attempt to ban the technique was overwhelmingly rejected. At issue is a bill that permits scientists to blend human and animal DNA to make “chimeric” embryos from which stem cells can be extracted.

Scientists say the technique could aid the understanding of genetic defects and diseases like Parkinson’s and Alzheimer’s. But critics, who’ve taken a more hysterical view of the mingling of human and animal DNA, call it a monstrous attack on human rights, human dignity and human life. To them so-called “human-admixed embryos” recall the creatures of Marlon Brando’s fey, muumuu-wearing Dr. Moreau and his fantastical island.

Said MP Edward Leigh: “In embryos you do have the genetic makeup of a complete human being, and you cannot splice together a human and an animal. I’m not sure even my greatest political enemies would say that I was 30% a daffodil and 80% a mouse. I don’t believe in my soul or my brain I’m 80% a mouse or 30% a daffodil. But I do think that we are special and, therefore, as the human race is special, it is different from the animal race. And I think that we should take this very seriously.”

Thirty percent daffodil? Eighty percent mouse? Oh, you’re special all right, Leigh. Sure you read the right bill?

Anyway, as New Scientist’s Linda Geddes points out, this is all much ado about nothing. These “human-admixed embryos” aren’t really any more monstrous than you or I. “These embryos contain 99.9% human DNA, and 0.01% animal DNA,” writes Geddes. “Arguably I’m less than 99.9% human myself. Once you consider the billions of bacteria living in my gut and on my skin, the parasitic worms which may or may not be colonizing my intestines, and the fungi causing the itch between my toes, I’m a walking menagerie. In fact, some scientists have estimated that the total number of microbial genes in the human body outnumber human genes by up to 1,000 to 1.”

There is no gene for the human spirit.

Only one criterion : genetic perfection.”

–Taglines from the film “Gattaca”

The Genetic Nondiscrimination Act of 2007, which would prevent health insurers and employers from using genetic information in decisions of employment or insurability, will soon be signed into law. And, given recent advances in retail genetics it really couldn’t happen at a better time.

This morning the Google-funded 23andMe opened its doors for business, and began peddling its Personal Genome Service. What, exactly is a “Personal Genome Service?” Kara Swisher explains:

For [$999], a person spits out a largish saliva sample using an at-home kit, sends it in for intense analysis and then uses the site’s interactive tools to go to town with the scads of the DNA information.

“That could mean everything from analyzing personal ancestry and genealogy to determining inherited traits to finding out way too much about proclivities for a range of scary diseases.”

There is no gene for the human spirit.

Only one criterion : genetic perfection.”

–Taglines from the film “Gattaca”

The Genetic Nondiscrimination Act of 2007, which would prevent health insurers and employers from using genetic information in decisions of employment or insurability, will soon be signed into law. And, given recent advances in retail genetics it really couldn’t happen at a better time.

This morning the Google-funded 23andMe opened its doors for business, and began peddling its Personal Genome Service. What, exactly is a “Personal Genome Service?” Kara Swisher explains:

For [$999], a person spits out a largish saliva sample using an at-home kit, sends it in for intense analysis and then uses the site’s interactive tools to go to town with the scads of the DNA information.

“That could mean everything from analyzing personal ancestry and genealogy to determining inherited traits to finding out way too much about proclivities for a range of scary diseases.”

So I paid a visit a few weeks ago to the new offices of 23andMe, a start-up that has gotten a lot of attention for its unusual aim of joining together DNA research and social networking.

It’s an arena sure to be interesting, so here’s a video I made of my tour of 23andMe:

The service, which rolls out today with the launch of its Web site, bills itself as a “Personal Genome Service” and its motto is “Genetics Just Got Personal.”

And, indeed, the company–as well as several others (such as also Silicon Valley-based Navigenics)–hope a lot of people want to learn about their genes and what that information means, all in an attempt to carve out a lucrative new Web space by making DNA consumer-friendly.

The goal? For 23andMe, getting mainstream consumers to pay $999 for a personalized genomics assessment. For that price, a person spits out a largish saliva sample using an at-home kit, sends it in for intense analysis and then uses the site’s interactive tools to go to town with the scads of the DNA information.

That could mean everything from analyzing personal ancestry and genealogy to determining inherited traits to finding out way too much about proclivities for a range of scary diseases.

That presumably sets the stage for endlessly discussing all this genetic information within various personal and public social networks that might form. The font of all this juicy data comes from the 23 pairs of chromosomes that make up each individual’s genome.

Hence, the company’s unusual name.

Also noteworthy has been the funding around the company, especially a $3.9 million investment from Google. The company initially had an early investment from Google co-founder Sergey Brin, whose investment was replaced by Google’s.

The issue? He was recently married to 23andMe co-founder Anne Wojcicki (in addition, her sister Susan is a high-ranking executive at Google and provided Brin and other co-founder Larry Page with a garage space where the search company was first located).

This, of course, has attracted a lot of scrutiny to 23andMe’s founding–should Google have made the investment, even in an arms-length manner the company has said it used in determining its involvement, with someone so closely linked to Brin?–even though both Wojcicki and Linda Avey have much previous experience in the health-care and biotech sectors.

If the payoff is big, that issue will become moot. Other 23andMe investors are no slouches either, including Genentech and New Enterprise Associates. (Navigenics also has big backers in venture powerhouses Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures and Sequoia Capital.)

Of course, there might be even bigger controversies for all these companies, ranging from: the potential confusion all this detailed health information might bring to consumers; the thorny issues around privacy and the possibility that insurance companies might want to grab this rich vein of genetic information as it becomes available; and even the chance that some current genetic analysis given might turn out to be completely wrong.

Here are links to Part 1 and Part 2 of a longer interview I did with Avey and Wojcicki.

Please see this disclosure related to me and Google.

The company name comes from the 23 pairs of chromosomes that make up each individual’s genome.

In this part, they talk about the privacy of DNA information and why we should trust any of these services, what the goal of collecting all this genetic information is, what it is like for two women to run a Web company and their own personal genetic details:

In addition, here’s a tour of the 23andMe offices and the first part of the interview.

Please see this disclosure related to me and Google (an investor in 23andMe).

The company name comes from the 23 pairs of chromosomes that make up each individual’s genome.

In this part, they talk about why customers would want to know a lot about their DNA and whether that information is helpful and informative (tracing your ancient lineage) or just plain scary (you could have a proclivity for a zillion scary diseases you never heard of before!):

In addition, here’s a tour of the 23andMe offices and the second part of the interview.

Please see this disclosure related to me and Google (an investor in 23andMe).